Small airways targeting of inhaled steroids for severe therapy resistant asthma in children

Sanne Kloosterman (Rotterdam, Netherlands), Sanne F. Kloosterman, Harm A.W.M. Tiddens, Joke L. Overweel, Johan C. De Jongste, Hettie M. Janssens

Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Session: Paediatric asthma and allergy: asthma management
Session type: Thematic Poster Session
Number: 1283
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sanne Kloosterman (Rotterdam, Netherlands), Sanne F. Kloosterman, Harm A.W.M. Tiddens, Joke L. Overweel, Johan C. De Jongste, Hettie M. Janssens. Small airways targeting of inhaled steroids for severe therapy resistant asthma in children. Eur Respir J 2015; 46: Suppl. 59, 1283

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Relationship of large and small airway response with inhaled corticosteroids to asthma control
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013

Induced sputum in children With persistent asthma: The effect to inhaled corticosteroid treatment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016


Achievement of asthma control in patients with cold airway hyperresponsiveness at different variants of basic therapy
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013


Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Dose-response effect of small particle vs standard size particle inhaled corticosteroids on severe asthma exacerbations by sex
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airway
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


The remarkable role of adherence to inhaled corticosteroids in achieving asthma control in young children with asthma
Source: Annual Congress 2013 –Preschool wheeze
Year: 2013

Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Long-acting anticholinergics in the treatment of severe asthma with irreversible airway obstruction
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014

Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013


A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Combination therapy of ICSs/LABAs plus montelucastin patients with severe asthma
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015

A treatment algorithm adjusting oral corticosteroid using blood eosinophils reduces exacerbations and improves asthma control, in difficult asthmatics
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Clinical effectiveness of anti-IgE therapy in allergic severe asthma
Source: International Congress 2014 – Asthma and COPD management
Year: 2014

A predictive model of failed stepping-down of inhaled corticosteroids in adult asthmatics
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016


Effectively targeting small airways using controlled inhalation for peripheral corticosteroid deposition
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014